ChinaFile Recommends
08.06.18How China Is Evolving From a Maker of Copycat Medicines Into a Producer of Complex Drugs
Wall Street Journal
At a cancer conference in Chicago in June last year, a little-known Chinese startup stunned researchers with early results showing its experimental gene therapy was abating an aggressive form of blood cancer in patients back home.
Caixin Media
05.17.16
Government Forces Big Pharma to Swallow a Bitter Pill
China’s latest round of healthcare market controls could be a bitter pill for multinational pharmaceutical companies that now, after years of what some call easy profits, are adapting to a tougher business climate.The National Health and Family...
The China Africa Project
03.06.15
China’s BIG Gamble in the TINY Comoros Islands
Comoros is a tiny archipelago nation off the east coast of Africa in the Indian ocean where a major Chinese experiment is underway. Chinese scientists and pharmaceutical have undertaken a radical experiment to test an unlicensed anti-malarial herbal...
Caixin Media
12.09.13
Traditional Chinese Medicine Struggling to Find Cure for Regulatory Woes in the U.S.
In November, the traditional Chinese medicine (TCM) Fuzheng Huayu Tablets passed the second phase of the U.S. Food and Drug Administration’s (FDA) clinical testing.Before this, only one TCM drug had cleared the second of the three phases needed for...
ChinaFile Recommends
07.17.13For Global Drug Manufacturers, China Becomes a Perilous Market
New York Times
Selling pharmaceuticals and other health care products in China is increasingly fraught with peril. China is accusing GlaxoSmithKline of funnelling payments through travel agents to doctors, hospitals and government officials to bolster...